ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bearish•Celltrion Healthcare
•30 Aug 2018 10:29

Another Negative Sign for Celltrion: Remsima Retail Price Is Falling Too Fast Too Much

Celltrion Healthcare (091990 KS) submitted its 1H18 semi-annual report yesterday. And with this semi-annual report, we finally got to know the...

Logo
858 Views
Share
bearish•Celltrion Inc
•08 Aug 2018 03:59

Celltrion: Manufacturing Risks Remain

Celltrion Inc (068270 KS) continues to struggle with meeting the USFDA's standards for Good Manufacturing Practices. The agency issued a Form 483...

Share
bearish•Celltrion Inc
•26 Jul 2018 11:26

Sell Celltrion Inc (068270 KS): Story Unravelling

UPDATE: J&J release Q2 results - 24th July 2018 J&J’s US Remicade sales were flat QoQ. This undermines the story that Celltrion Group is...

bullish•Samsung Biologics
•13 Jul 2018 01:56

Samsung BioLogics (207940 KS): Korea FSC Ruling Summary & Clarifications

This Korea FSC's final ruling on Samsung Biologics Co., Ltd (207940 KS)'s accounting fraud case is very confusing. So, let me walk you...

Logo
953 Views
Share
•04 Jun 2018 20:23

Japan & Korea @Smartkarma:  Autos, Toshiba, NTT, JDI, North Korean Détente, and Trump Trade

As these weekly summaries get written on a weekend we look at things on a Friday-to-Friday schedule but things move at a fast pace. Just a week can...

Logo
267 Views
Share
x